“Evaluation of 1,5-Anhydroglucitol As a Biomarker for Type 2 Diabetes Mellitus in Patients Without Overt Nephropathy”. 2022. Brazilian Journal of Pharmaceutical Sciences 57 (November). https://doi.org/10.1590/s2175-97902020000419078.